Global Brazzein Market Overview:
Brazzein is a protein that is obtained from the berry of Pentadiplandra brazzeana Ballion, a West African plant. The sweetness of this protein is way more than sucrose. Commercialization of brazzein is an ongoing process for which the patent is not obtained. This has restricted the commercialization of brazzein. Brazzein represents an alternative to available low-calorie sweeteners. The Indian market for natural alternative sweeteners is bound to expand. Pharma majors are eyeing this category and are keen to add sweeteners to their diabetic product portfolios. The industry is discovering more options and looking forward to introducing newer and safer alternatives for the healthy-minded consumers who can look forward to sweeter days ahead.
- Increasing Geriatric Population
- High Demand of Brazzein in the Developed Countries owing to Its Properties
- Growing Awareness among Consumers for Healthy Diet
- Trends towards Natural and Healthy Ingredients
- Difficulties in Getting Funding or Attract Foreign Investment
- High priced feedstock, Low Yield, Scarce Growth, and Costly Extraction Processes
- Increasing Awareness and Endorsements by Culinary Experts and Cine Personalities
- Increasing R&D by Pharmaceutical and Consumer Companies on Natural Alternatives for the Indian Market
- Difficulties of Obtaining Brazzein from Its Natural Source
- Purification from Fruit in Commercial Scale is Difficult
Some of the key players profiled in the report are Natur Research Ingredients (United States), MB Group USA (United States), AmideBio (United States) and Magellan Life Sciences Ltd. (United Kingdom). Analyst at AMA Research see United States Vendors to retain maximum share of Global Brazzein market by 2026. Considering Market by Source, the sub-segment i.e. Oubli Plant will boost the Brazzein market.
On July 11, 2018, UK-based Magellan Life Sciences has scaled up its production of brazzein, through its patent-pending fermentation process. The company believes it will be the first to market the natural sweetener on a major scale.
A high-intensity sweetener is regulated as a food additive unless its use as a sweetener is generally recognized as safe (GRAS). The use of a food additive must undergo premarket review and approval by FDA before it can be used in food.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Brazzein market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Brazzein market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Brazzein Manufacturers, Raw Material Suppliers, Food & Beverage Companies, Research Institutes, Traders/Distributors/Exporters/Importers and Industry Bodies & Associations.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.